chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site swelling, Vaccination site warmth
Clinical narrative: Hotness in right arm; Itchiness on right arm; Burning in right arm; Swelling in the right armpit; Swelling in right arm; Rash on right arm; Soreness in the right armpit; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of VACCINATION SITE WARMTH (Hotness in right arm), VACCINATION SITE PRURITUS (Itchiness on right arm), VACCINATION SITE SWELLING (Swelling in right arm), VACCINATION SITE RASH (Rash on right arm) and AXILLARY PAIN (Soreness in the right armpit) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 18-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Jan-2021, the patient experienced VACCINATION SITE SWELLING (Swelling in right arm), VACCINATION SITE RASH (Rash on right arm), AXILLARY PAIN (Soreness in the right armpit) and VACCINATION SITE LYMPHADENOPATHY (Swelling in the right armpit). On 27-Jan-2021, the patient experienced VACCINATION SITE WARMTH (Hotness in right arm), VACCINATION SITE PRURITUS (Itchiness on right arm) and VACCINATION SITE PAIN (Burning in right arm). At the time of the report, VACCINATION SITE WARMTH (Hotness in right arm), VACCINATION SITE PRURITUS (Itchiness on right arm), VACCINATION SITE SWELLING (Swelling in right arm), VACCINATION SITE RASH (Rash on right arm), AXILLARY PAIN (Soreness in the right armpit), VACCINATION SITE PAIN (Burning in right arm) and VACCINATION SITE LYMPHADENOPATHY (Swelling in the right armpit) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not reported. Treatment medications included fluocinonide 0.05% cream, tylenol and Claritin.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Feeling cold, Nausea, Vomiting
Clinical narrative: threw up all night; feeling cold; nausea; having chills; This spontaneous case was reported by a non-health professional (subsequently medically confirmed) and describes the occurrence of FEELING COLD (feeling cold), NAUSEA (nausea), CHILLS (having chills) and VOMITING (threw up all night) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Jan-2021, the patient experienced FEELING COLD (feeling cold), NAUSEA (nausea) and CHILLS (having chills). On 31-Jan-2021, the patient experienced VOMITING (threw up all night). At the time of the report, FEELING COLD (feeling cold), NAUSEA (nausea), CHILLS (having chills) and VOMITING (threw up all night) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were provided by the reporter. No treatment medications were reported.
Age: 31.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Chills, Feeling cold, Nausea, SARS-CoV-2 test positive
Clinical narrative: feeling cold; chills; Nausea; threw up all night; tested positive for COVID; This spontaneous case was reported by a nurse (subsequently medically confirmed) and describes the occurrence of SARS-COV-2 TEST POSITIVE (tested positive for COVID), FEELING COLD (feeling cold), CHILLS (chills), NAUSEA (Nausea) and VOMITING (threw up all night) in a 31-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination.     No medical history was provided by reporter.  Concomitant products included VENLAFAXINE HYDROCHLORIDE (EFFEXOR), HYDROXYZINE and LAMOTRIGINE (LAMICTAL) for an unknown indication.    On 08-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Jan-2021, the patient experienced SARS-COV-2 TEST POSITIVE (tested positive for COVID). On an unknown date, the patient experienced FEELING COLD (feeling cold), CHILLS (chills), NAUSEA (Nausea) and VOMITING (threw up all night). On 27-Jan-2021, SARS-COV-2 TEST POSITIVE (tested positive for COVID) had resolved. At the time of the report, FEELING COLD (feeling cold), CHILLS (chills), NAUSEA (Nausea) and VOMITING (threw up all night) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 11-Jan-2021, COVID-19: (Positive) tested positive for COVID.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment information is not provided by reporter.   Most recent FOLLOW-UP information incorporated above includes: On 20-Apr-2021: Follow up received and added new events Feeling cold, chills, nausea, threw up all night.
Age: 31.0
Sex: M
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: feeling cold; chills; Nausea; threw up all night; tested positive for COVID; This spontaneous case was reported by a nurse (subsequently medically confirmed) and describes the occurrence of SARS-COV-2 TEST POSITIVE (tested positive for COVID), FEELING COLD (feeling cold), CHILLS (chills), NAUSEA (Nausea) and VOMITING (threw up all night) in a 31-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination.     No medical history was provided by reporter.  Concomitant products included VENLAFAXINE HYDROCHLORIDE (EFFEXOR), HYDROXYZINE and LAMOTRIGINE (LAMICTAL) for an unknown indication.    On 08-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Jan-2021, the patient experienced SARS-COV-2 TEST POSITIVE (tested positive for COVID). On an unknown date, the patient experienced FEELING COLD (feeling cold), CHILLS (chills), NAUSEA (Nausea) and VOMITING (threw up all night). On 27-Jan-2021, SARS-COV-2 TEST POSITIVE (tested positive for COVID) had resolved. At the time of the report, FEELING COLD (feeling cold), CHILLS (chills), NAUSEA (Nausea) and VOMITING (threw up all night) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 11-Jan-2021, COVID-19: (Positive) tested positive for COVID.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment information is not provided by reporter.   Most recent FOLLOW-UP information incorporated above includes: On 20-Apr-2021: Follow up received and added new events Feeling cold, chills, nausea, threw up all night.
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test, SARS-CoV-2 test positive
Clinical narrative: She tested positive to the virus and had been under quarentine for the pass 14 days; This spontaneous case was reported by a consumer and describes the occurrence of SARS-COV-2 TEST POSITIVE (She tested positive to the virus and had been under quarentine for the pass 14 days) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced SARS-COV-2 TEST POSITIVE (She tested positive to the virus and had been under quarentine for the pass 14 days). At the time of the report, SARS-COV-2 TEST POSITIVE (She tested positive to the virus and had been under quarentine for the pass 14 days) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter.  Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 15-Jun-2021: Additional information received: Patient had declined further follow-up. Patient stated that she was doing fine currently.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Erythema, Gingival blister
Clinical narrative: chills, blisters in my mouth; chills, blisters in my mouth; bright red face; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (chills, blisters in my mouth), GINGIVAL BLISTER (chills, blisters in my mouth) and ERYTHEMA (bright red face) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced CHILLS (chills, blisters in my mouth), GINGIVAL BLISTER (chills, blisters in my mouth) and ERYTHEMA (bright red face). At the time of the report, CHILLS (chills, blisters in my mouth), GINGIVAL BLISTER (chills, blisters in my mouth) and ERYTHEMA (bright red face) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.   Reporter did not allow further contact
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site pain, Injection site pruritus, Injection site swelling, Injection site warmth
Clinical narrative: 2 inches of red circle around the injection site; it has been hot; around the injection site has been sore; around the injection site has been swollen; around the injection site has been itchy; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE ERYTHEMA (2 inches of red circle around the injection site), INJECTION SITE WARMTH (it has been hot), INJECTION SITE PAIN (around the injection site has been sore), INJECTION SITE SWELLING (around the injection site has been swollen) and INJECTION SITE PRURITUS (around the injection site has been itchy) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Jan-2021, the patient experienced INJECTION SITE ERYTHEMA (2 inches of red circle around the injection site), INJECTION SITE WARMTH (it has been hot), INJECTION SITE PAIN (around the injection site has been sore), INJECTION SITE SWELLING (around the injection site has been swollen) and INJECTION SITE PRURITUS (around the injection site has been itchy). The patient was treated with LORATADINE (CLARITINE) ongoing since an unknown date at a dose of 1 dosage form. At the time of the report, INJECTION SITE ERYTHEMA (2 inches of red circle around the injection site), INJECTION SITE WARMTH (it has been hot), INJECTION SITE PAIN (around the injection site has been sore), INJECTION SITE SWELLING (around the injection site has been swollen) and INJECTION SITE PRURITUS (around the injection site has been itchy) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided by reporter.   Most recent FOLLOW-UP information incorporated above includes: On 16-Apr-2021: Follow up received
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Pruritus, Rash
Clinical narrative: extreme itching on his lower legs,little itching on his ankles and feet; rash spread on most of his body,mild rash on his ankles and feet; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (extreme itching on his lower legs,little itching on his ankles and feet) and RASH (rash spread on most of his body,mild rash on his ankles and feet) in a 74-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination.     No medical history was updated by reporter.  Concomitant products included CHOLESTEROL for an unknown indication.    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Jan-2021, the patient experienced PRURITUS (extreme itching on his lower legs,little itching on his ankles and feet) and RASH (rash spread on most of his body,mild rash on his ankles and feet). At the time of the report, PRURITUS (extreme itching on his lower legs,little itching on his ankles and feet) and RASH (rash spread on most of his body,mild rash on his ankles and feet) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant products included medicine for blood pressure. Treatment included antihistamines, a steroid cream and a Benadryl cream.
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Oropharyngeal pain, SARS-CoV-2 test positive
Clinical narrative: Tested positive for COVID-19 after first dose; Sore throat; Headache; This spontaneous case was reported by a health care professional (subsequently medically confirmed) and describes the occurrence of SARS-COV-2 TEST POSITIVE (Tested positive for COVID-19 after first dose), OROPHARYNGEAL PAIN (Sore throat) and HEADACHE (Headache) in a 26-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Jan-2021, the patient experienced OROPHARYNGEAL PAIN (Sore throat) and HEADACHE (Headache). On an unknown date, the patient experienced SARS-COV-2 TEST POSITIVE (Tested positive for COVID-19 after first dose). At the time of the report, SARS-COV-2 TEST POSITIVE (Tested positive for COVID-19 after first dose), OROPHARYNGEAL PAIN (Sore throat) and HEADACHE (Headache) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 20-Jan-2021, SARS-CoV-2 test positive: (Positive) COVID-antigen PCR-Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment medication include Acetaminophen. No concomitant medications were provided by reporter.
Sex: F
Vaccine: COVID19
Symptoms: Rosacea
Clinical narrative: rosacea; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of ROSACEA (rosacea) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Rosacea.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ROSACEA (rosacea). The patient was treated with DOXYCYCLINE for Rosacea, at a dose of 1 dosage form. At the time of the report, ROSACEA (rosacea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided by reporter.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Fatigue, Injection site erythema, Injection site pruritus
Clinical narrative: achy; local injection site reaction with itching; local injection site reaction with redness; local injection site reaction with swelling about walnut size; She felt fatigued; queasy; as soreness in her joints which was worse than her baseline; She has also felt feverish and chilled; chilled/shivering; pain in her injection arm; This spontaneous case was reported by a patient and describes the occurrence of FATIGUE (She felt fatigued), NAUSEA (queasy), ARTHRALGIA (as soreness in her joints which was worse than her baseline), PYREXIA (She has also felt feverish and chilled) and CHILLS (chilled/shivering) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 032L20A and 026L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Fatigue, Depressed state and Surgery on 07-Dec-2020. Concurrent medical conditions included UTI and Hypertension. Concomitant products included VALSARTAN for Hypertension, LEVOTHYROXINE for an unknown indication.   On 28-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Jan-2021 at 12:00 PM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 25-Jan-2021, the patient experienced FATIGUE (She felt fatigued), NAUSEA (queasy), ARTHRALGIA (as soreness in her joints which was worse than her baseline), PYREXIA (She has also felt feverish and chilled), CHILLS (chilled/shivering), VACCINATION SITE PAIN (pain in her injection arm), INJECTION SITE PRURITUS (local injection site reaction with itching), INJECTION SITE ERYTHEMA (local injection site reaction with redness) and INJECTION SITE SWELLING (local injection site reaction with swelling about walnut size). On an unknown date, the patient experienced MYALGIA (achy). The patient was treated with Bed rest (AND PUSHING LIQUIDS) for Fatigue; Bed rest (AND PUSHING LIQUIDS) for Nausea; Bed rest (AND PUSHING LIQUIDS) for Arthralgia; Bed rest (AND PUSHING LIQUIDS) for Pyrexia; Bed rest (AND PUSHING LIQUIDS) for Chills and Bed rest (AND PUSHING LIQUIDS) for Vaccination site pain. At the time of the report, FATIGUE (She felt fatigued), NAUSEA (queasy), ARTHRALGIA (as soreness in her joints which was worse than her baseline), PYREXIA (She has also felt feverish and chilled), CHILLS (chilled/shivering), VACCINATION SITE PAIN (pain in her injection arm), MYALGIA (achy), INJECTION SITE PRURITUS (local injection site reaction with itching), INJECTION SITE ERYTHEMA (local injection site reaction with redness) and INJECTION SITE SWELLING (local injection site reaction with swelling about walnut size) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment medications included Antibiotics.   This case was linked to MOD-2021-072822 (Patient Link).
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site swelling, Myalgia, Nausea, Pyrexia, Vaccination site pain
Clinical narrative: achy; local injection site reaction with itching; local injection site reaction with redness; local injection site reaction with swelling about walnut size; She felt fatigued; queasy; as soreness in her joints which was worse than her baseline; She has also felt feverish and chilled; chilled/shivering; pain in her injection arm; This spontaneous case was reported by a patient and describes the occurrence of FATIGUE (She felt fatigued), NAUSEA (queasy), ARTHRALGIA (as soreness in her joints which was worse than her baseline), PYREXIA (She has also felt feverish and chilled) and CHILLS (chilled/shivering) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 032L20A and 026L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Fatigue, Depressed state and Surgery on 07-Dec-2020. Concurrent medical conditions included UTI and Hypertension. Concomitant products included VALSARTAN for Hypertension, LEVOTHYROXINE for an unknown indication.   On 28-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Jan-2021 at 12:00 PM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 25-Jan-2021, the patient experienced FATIGUE (She felt fatigued), NAUSEA (queasy), ARTHRALGIA (as soreness in her joints which was worse than her baseline), PYREXIA (She has also felt feverish and chilled), CHILLS (chilled/shivering), VACCINATION SITE PAIN (pain in her injection arm), INJECTION SITE PRURITUS (local injection site reaction with itching), INJECTION SITE ERYTHEMA (local injection site reaction with redness) and INJECTION SITE SWELLING (local injection site reaction with swelling about walnut size). On an unknown date, the patient experienced MYALGIA (achy). The patient was treated with Bed rest (AND PUSHING LIQUIDS) for Fatigue; Bed rest (AND PUSHING LIQUIDS) for Nausea; Bed rest (AND PUSHING LIQUIDS) for Arthralgia; Bed rest (AND PUSHING LIQUIDS) for Pyrexia; Bed rest (AND PUSHING LIQUIDS) for Chills and Bed rest (AND PUSHING LIQUIDS) for Vaccination site pain. At the time of the report, FATIGUE (She felt fatigued), NAUSEA (queasy), ARTHRALGIA (as soreness in her joints which was worse than her baseline), PYREXIA (She has also felt feverish and chilled), CHILLS (chilled/shivering), VACCINATION SITE PAIN (pain in her injection arm), MYALGIA (achy), INJECTION SITE PRURITUS (local injection site reaction with itching), INJECTION SITE ERYTHEMA (local injection site reaction with redness) and INJECTION SITE SWELLING (local injection site reaction with swelling about walnut size) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment medications included Antibiotics.   This case was linked to MOD-2021-072822 (Patient Link).
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Platelet count, Platelet count decreased, White blood cell count, White blood cell count decreased
Clinical narrative: white blood cells and plackets were low; white blood cells and plackets were low; Pain in her arm; This spontaneous case was reported by a consumer and describes the occurrence of WHITE BLOOD CELL COUNT DECREASED (white blood cells and plackets were low), PLATELET COUNT DECREASED (white blood cells and plackets were low) and PAIN IN EXTREMITY (Pain in her arm) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Jan-2021, the patient experienced PAIN IN EXTREMITY (Pain in her arm). On 14-Jan-2021, the patient experienced WHITE BLOOD CELL COUNT DECREASED (white blood cells and plackets were low) and PLATELET COUNT DECREASED (white blood cells and plackets were low). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form. At the time of the report, WHITE BLOOD CELL COUNT DECREASED (white blood cells and plackets were low), PLATELET COUNT DECREASED (white blood cells and plackets were low) and PAIN IN EXTREMITY (Pain in her arm) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 14-Jan-2021, Platelet count: (Low) Low. On 14-Jan-2021, White blood cell count: (Low) Low.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided.
Age: 76.0
Sex: U
Vaccine: COVID19
Symptoms: Injection site pruritus, Injection site rash
Clinical narrative: Injection site Rash about 3"; Minor injection site Itching; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE RASH (Injection site Rash about 3") and INJECTION SITE PRURITUS (Minor injection site Itching) in a 76-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced INJECTION SITE RASH (Injection site Rash about 3") and INJECTION SITE PRURITUS (Minor injection site Itching). At the time of the report, INJECTION SITE RASH (Injection site Rash about 3") and INJECTION SITE PRURITUS (Minor injection site Itching) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Relevant concomitant medications were not reported. Treatment information was provided as diphenhydramine.     Reporter did not allow further contact
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Muscle tightness
Clinical narrative: tiredness x5 days; muscle tension in her neck/ muscle tension in her back/ muscle tension in her jaw; This spontaneous case was reported by a consumer and describes the occurrence of MUSCLE TIGHTNESS (muscle tension in her neck/ muscle tension in her back/ muscle tension in her jaw) and FATIGUE (tiredness x5 days) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Lung cancer.   On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 07-Jan-2021, the patient experienced MUSCLE TIGHTNESS (muscle tension in her neck/ muscle tension in her back/ muscle tension in her jaw). On 08-Jan-2021, the patient experienced FATIGUE (tiredness x5 days). At the time of the report, MUSCLE TIGHTNESS (muscle tension in her neck/ muscle tension in her back/ muscle tension in her jaw) and FATIGUE (tiredness x5 days) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication and treatment information were provided.   Reporter did not allow further contact
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Fatigue, Illness, Nausea, Psoriasis
Clinical narrative: Sick; Psoriasis flare up; Joint pain; Fever; Fatigue; Extreme nausea; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (Sick), PSORIASIS (Psoriasis flare up), ARTHRALGIA (Joint pain), PYREXIA (Fever) and FATIGUE (Fatigue) in a 41-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025J20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Psoriasis.    On 25-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ILLNESS (Sick), PSORIASIS (Psoriasis flare up), ARTHRALGIA (Joint pain), PYREXIA (Fever), FATIGUE (Fatigue) and NAUSEA (Extreme nausea). At the time of the report, ILLNESS (Sick), PSORIASIS (Psoriasis flare up), ARTHRALGIA (Joint pain), PYREXIA (Fever), FATIGUE (Fatigue) and NAUSEA (Extreme nausea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment and concomitant medications were not provided by reporter.   This case was linked to US-MODERNATX, INC.-MOD-2021-021756, US-MODERNATX, INC.-MOD-2021-021756 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-021756: US-MODERNATX, INC.-MOD-2021-021756:Crosslinked (MOD21-021976)
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Sick; Psoriasis flare up; Joint pain; Fever; Fatigue; Extreme nausea; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (Sick), PSORIASIS (Psoriasis flare up), ARTHRALGIA (Joint pain), PYREXIA (Fever) and FATIGUE (Fatigue) in a 41-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025J20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Psoriasis.    On 25-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ILLNESS (Sick), PSORIASIS (Psoriasis flare up), ARTHRALGIA (Joint pain), PYREXIA (Fever), FATIGUE (Fatigue) and NAUSEA (Extreme nausea). At the time of the report, ILLNESS (Sick), PSORIASIS (Psoriasis flare up), ARTHRALGIA (Joint pain), PYREXIA (Fever), FATIGUE (Fatigue) and NAUSEA (Extreme nausea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment and concomitant medications were not provided by reporter.   This case was linked to US-MODERNATX, INC.-MOD-2021-021756, US-MODERNATX, INC.-MOD-2021-021756 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-021756: US-MODERNATX, INC.-MOD-2021-021756:Crosslinked (MOD21-021976)
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site lymphadenopathy
Clinical narrative: Swollen lymph nodes in left arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE LYMPHADENOPATHY (Swollen lymph nodes in left arm) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Jan-2021, the patient experienced VACCINATION SITE LYMPHADENOPATHY (Swollen lymph nodes in left arm). The patient was treated with Manual therapy (Cold compresses) for Vaccination site lymphadenopathy. At the time of the report, VACCINATION SITE LYMPHADENOPATHY (Swollen lymph nodes in left arm) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded. Further information has been requested.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Induration, Vaccination site erythema, Vaccination site lymphadenopathy
Clinical narrative: had little circle with small lymph on it at injection site on her left arm; approx 5-6 days later the following week the redness started to spread from topical side and past; hard to touch; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of VACCINATION SITE LYMPHADENOPATHY (had little circle with small lymph on it at injection site on her left arm), VACCINATION SITE ERYTHEMA (approx 5-6 days later the following week the redness started to spread from topical side and past) and INDURATION (hard to touch) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011L20A) for COVID-19 immunization.     The patient's past medical history included Multiple sclerosis (from last 40 years).    On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE LYMPHADENOPATHY (had little circle with small lymph on it at injection site on her left arm), VACCINATION SITE ERYTHEMA (approx 5-6 days later the following week the redness started to spread from topical side and past) and INDURATION (hard to touch). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at a dose of 1 dosage form. At the time of the report, VACCINATION SITE LYMPHADENOPATHY (had little circle with small lymph on it at injection site on her left arm), VACCINATION SITE ERYTHEMA (approx 5-6 days later the following week the redness started to spread from topical side and past) and INDURATION (hard to touch) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications were not provided by reporter.
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Limb discomfort, Neuralgia, Pain
Clinical narrative: Nerve pain in shoulder; Arm weakness; Soreness was getting worse daily; Having trouble raising arm; This spontaneous case was reported by a consumer and describes the occurrence of NEURALGIA (Nerve pain in shoulder), ASTHENIA (Arm weakness), PAIN (Soreness was getting worse daily) and LIMB DISCOMFORT (Having trouble raising arm) in a 60-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced NEURALGIA (Nerve pain in shoulder), ASTHENIA (Arm weakness), PAIN (Soreness was getting worse daily) and LIMB DISCOMFORT (Having trouble raising arm). At the time of the report, NEURALGIA (Nerve pain in shoulder), ASTHENIA (Arm weakness), PAIN (Soreness was getting worse daily) and LIMB DISCOMFORT (Having trouble raising arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information was not provided.
Sex: M
Vaccine: COVID19
Symptoms: Chills, Feeling cold, Migraine, Tremor
Clinical narrative: Shaking; Excruciating migraine; Whole body is freezing; felt Cold; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of TREMOR (Shaking), FEELING COLD (felt Cold), MIGRAINE (Excruciating migraine) and CHILLS (Whole body is freezing) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037K20A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Jan-2020, the patient experienced FEELING COLD (felt Cold). On 14-Jan-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced TREMOR (Shaking), MIGRAINE (Excruciating migraine) and CHILLS (Whole body is freezing). On 15-Jan-2021, MIGRAINE (Excruciating migraine) had resolved. At the time of the report, TREMOR (Shaking), FEELING COLD (felt Cold) and CHILLS (Whole body is freezing) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided.   Treatment information include patient Health Care Provider told her to take Benadryl.   Most recent FOLLOW-UP information incorporated above includes: On 21-Apr-2021: NNI
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Eczema, Paraesthesia, Pruritus, Rash, Rash erythematous
Clinical narrative: rash over arms,The area has grown and now cover the upper arm and even down the elbow,it covers 3/4 of the arm and the only thing that doesn't cover is the inside of the arm.; tingly feeling; itchy; still has the tingly feeling, that called itchy before; the center is more pink and not so warm to the touch; feels like small bubbles under the skin; This spontaneous case was reported by a consumer and describes the occurrence of RASH (rash over arms,The area has grown and now cover the upper arm and even down the elbow,it covers 3/4 of the arm and the only thing that doesn't cover is the inside of the arm.), PARAESTHESIA (tingly feeling), PRURITUS (itchy), PARAESTHESIA (still has the tingly feeling, that called itchy before) and RASH ERYTHEMATOUS (the center is more pink and not so warm to the touch) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced RASH (rash over arms,The area has grown and now cover the upper arm and even down the elbow,it covers 3/4 of the arm and the only thing that doesn't cover is the inside of the arm.), PARAESTHESIA (tingly feeling), PRURITUS (itchy), PARAESTHESIA (still has the tingly feeling, that called itchy before), RASH ERYTHEMATOUS (the center is more pink and not so warm to the touch) and ECZEMA (feels like small bubbles under the skin). At the time of the report, RASH (rash over arms,The area has grown and now cover the upper arm and even down the elbow,it covers 3/4 of the arm and the only thing that doesn't cover is the inside of the arm.), PARAESTHESIA (tingly feeling), PRURITUS (itchy), PARAESTHESIA (still has the tingly feeling, that called itchy before), RASH ERYTHEMATOUS (the center is more pink and not so warm to the touch) and ECZEMA (feels like small bubbles under the skin) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Swelling
Clinical narrative: Very bad swelling around their neck/very severe/swelling came down a little but it is still swollen; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING (Very bad swelling around their neck/very severe/swelling came down a little but it is still swollen) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Jan-2021, the patient experienced SWELLING (Very bad swelling around their neck/very severe/swelling came down a little but it is still swollen). At the time of the report, SWELLING (Very bad swelling around their neck/very severe/swelling came down a little but it is still swollen) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Agitation, Back pain, Dyspnoea, Fatigue
Clinical narrative: Feeling tired; t's hard to breath; Get's agitated a lot; Back pain when she lays down; This spontaneous case was reported by a physician and describes the occurrence of FATIGUE (Feeling tired), DYSPNOEA (t's hard to breath), AGITATION (Get's agitated a lot) and BACK PAIN (Back pain when she lays down) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20A) for COVID-19 vaccination.     no medical history is provided and concomitant drugs are provided.  Concomitant products included PREGABALIN, LEVOTHYROXINE SODIUM (EUTHYROX), ASCORBIC ACID (VIT C), ZINC and FISH OIL for an unknown indication.    On 08-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Jan-2021, the patient experienced FATIGUE (Feeling tired), DYSPNOEA (t's hard to breath), AGITATION (Get's agitated a lot) and BACK PAIN (Back pain when she lays down). At the time of the report, FATIGUE (Feeling tired), DYSPNOEA (t's hard to breath), AGITATION (Get's agitated a lot) and BACK PAIN (Back pain when she lays down) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Sex: F
Vaccine: COVID19
Symptoms: Hypokinesia, Peripheral nerve lesion, Sciatica
Clinical narrative: Severe sciatic pain; Unable to move; Felt like her sciatic nerve was inflamed; This spontaneous case was reported by a nurse and describes the occurrence of SCIATICA (Severe sciatic pain), HYPOKINESIA (Unable to move) and PERIPHERAL NERVE LESION (Felt like her sciatic nerve was inflamed) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Feb-2021, the patient experienced SCIATICA (Severe sciatic pain), HYPOKINESIA (Unable to move) and PERIPHERAL NERVE LESION (Felt like her sciatic nerve was inflamed). The patient was treated with IBUPROFEN for Adverse event, at a dose of UNK dosage form. At the time of the report, SCIATICA (Severe sciatic pain) had not resolved and HYPOKINESIA (Unable to move) and PERIPHERAL NERVE LESION (Felt like her sciatic nerve was inflamed) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   concomitant medications were not provided.  Treatment for the event included  kept putting ice, cold compress, heat.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, COVID-19, Chills, Diarrhoea, Fatigue
Clinical narrative: Diarrhoea; Hurts all over body; Temperature 100.4; Fatigue; Chills; Joint pain; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Diarrhoea), PAIN (Hurts all over body), PYREXIA (Temperature 100.4), FATIGUE (Fatigue) and CHILLS (Chills) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 043L20A and 013M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Fibromyalgia. Concomitant products included MARIJUANA and FENTANYL (FENTANYL PATCH) for an unknown indication.   On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 23-Jan-2021, the patient experienced DIARRHOEA (Diarrhoea), PAIN (Hurts all over body), PYREXIA (Temperature 100.4), FATIGUE (Fatigue), CHILLS (Chills) and ARTHRALGIA (Joint pain). On 24-Jan-2021, DIARRHOEA (Diarrhoea), PYREXIA (Temperature 100.4), FATIGUE (Fatigue) and CHILLS (Chills) had resolved. At the time of the report, PAIN (Hurts all over body) and ARTHRALGIA (Joint pain) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 22-Jan-2021, COVID-19: (Negative) negative.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment of the events included, Imodium for diarrhea and marijuana for pain.   This case was linked to MOD-2021-098719 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 28-Apr-2021: Follow up information was received on 28 Apr 2021, contains NNI
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pyrexia
Clinical narrative: Diarrhoea; Hurts all over body; Temperature 100.4; Fatigue; Chills; Joint pain; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Diarrhoea), PAIN (Hurts all over body), PYREXIA (Temperature 100.4), FATIGUE (Fatigue) and CHILLS (Chills) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 043L20A and 013M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Fibromyalgia. Concomitant products included MARIJUANA and FENTANYL (FENTANYL PATCH) for an unknown indication.   On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 23-Jan-2021, the patient experienced DIARRHOEA (Diarrhoea), PAIN (Hurts all over body), PYREXIA (Temperature 100.4), FATIGUE (Fatigue), CHILLS (Chills) and ARTHRALGIA (Joint pain). On 24-Jan-2021, DIARRHOEA (Diarrhoea), PYREXIA (Temperature 100.4), FATIGUE (Fatigue) and CHILLS (Chills) had resolved. At the time of the report, PAIN (Hurts all over body) and ARTHRALGIA (Joint pain) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 22-Jan-2021, COVID-19: (Negative) negative.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment of the events included, Imodium for diarrhea and marijuana for pain.   This case was linked to MOD-2021-098719 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 28-Apr-2021: Follow up information was received on 28 Apr 2021, contains NNI
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Vaccination site erythema, Vaccination site swelling
Clinical narrative: Patient started experiencing dizziness; Noticed her arm was swollen at the injection site; Noticed her arm was red at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Patient started experiencing dizziness), VACCINATION SITE SWELLING (Noticed her arm was swollen at the injection site) and VACCINATION SITE ERYTHEMA (Noticed her arm was red at the injection site) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. LCHD) for COVID-19 vaccination.     No Medical History information was reported.  Concomitant products included CELECOXIB (CELEBREX) for an unknown indication.    On 26-Jan-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Jan-2021, the patient experienced VACCINATION SITE SWELLING (Noticed her arm was swollen at the injection site) and VACCINATION SITE ERYTHEMA (Noticed her arm was red at the injection site). On 28-Jan-2021, the patient experienced DIZZINESS (Patient started experiencing dizziness). The patient was treated with PARACETAMOL (TYLENOL) on 27-Jan-2021 for Adverse event, at a dose of two tylenol. At the time of the report, DIZZINESS (Patient started experiencing dizziness), VACCINATION SITE SWELLING (Noticed her arm was swollen at the injection site) and VACCINATION SITE ERYTHEMA (Noticed her arm was red at the injection site) outcome was unknown.            Products known to have been used by the patient, within two weeks prior to the event, included blood pressure medication.
Sex: F
Vaccine: COVID19
Symptoms: Adverse drug reaction
Clinical narrative: Patient had a very bad reaction; This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE DRUG REACTION (Patient had a very bad reaction) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history reported.).    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ADVERSE DRUG REACTION (Patient had a very bad reaction). At the time of the report, ADVERSE DRUG REACTION (Patient had a very bad reaction) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Very limited information regarding this event has been provided at this time.  Further information has been requested.; Sender's Comments: Very limited information regarding this event has been provided at this time.  Further information has been requested.